Understanding GLP-1 Agonists GLP-1 agonists, short for glucagon-like peptide-1 receptor agonists, are medications that mimic the effects of the naturally occurring hormone GLP-1
Sixty seconds on the cost of semaglutide
A 2023 study review showed that daily consumption of 10 ounces of pomegranate juice lowered systolic blood pressure (SBP), though drinking more did not provide additional benefits, and the effect lessened after two months
Bethany Tennant, N.D., C.N.S., is a naturopathic doctor and certified nutrition specialist in Portland, Oregon
27(4):299311 Physiological role of insulin-like growth factor I in endocrine and growth-related signaling pathways Disclaimer: For Laboratory Research Use Only (RUO)
Key Takeaways: Zepbound vs Wegovy Zepbound shows higher average weight loss: 22.5% vs 14.9% at maximum doses Zepbound (tirzepatide) acts on two hormone receptors, Wegovy (semaglutide) acts on one Both are FDA-approved specifically for chronic weight management Side effects similar but Zepbound may cause slightly more gastrointestinal issues Brand prices: Zepbound $1,069/month, Wegovy $1,349/month Compounded options: tirzepatide $349/month, semaglutide $199/month through TrimRx Insurance coverage inconsistent for both, many plans exclude weight loss medications Both require weekly self-injections using pre-filled pens Understanding Zepbound and Wegovy Both medications belong to a class called GLP-1 receptor agonists, though Zepbound technically goes beyond this single classification